Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease.

[1]  P. Burfeind,et al.  CHD7 mutations causing CHARGE syndrome are predominantly of paternal origin , 2012, Clinical genetics.

[2]  Qi Xu,et al.  Common variants on 8p12 and 1q24.2 confer risk of schizophrenia , 2011, Nature Genetics.

[3]  L. Vissers,et al.  De novo copy number variants associated with intellectual disability have a paternal origin and age bias , 2011, Journal of Medical Genetics.

[4]  S. Lok,et al.  Increased exonic de novo mutation rate in individuals with schizophrenia , 2011, Nature Genetics.

[5]  A. Wilkie,et al.  OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia , 2011, The Journal of pathology.

[6]  S. Levy,et al.  Exome sequencing supports a de novo mutational paradigm for schizophrenia , 2011, Nature Genetics.

[7]  M. DePristo,et al.  Variation in genome-wide mutation rates within and between human families , 2011, Nature Genetics.

[8]  Boris Yamrom,et al.  Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders , 2011, Neuron.

[9]  Michael Wigler,et al.  Rare De Novo Variants Associated with Autism Implicate a Large Functional Network of Genes Involved in Formation and Function of Synapses , 2011, Neuron.

[10]  M. Rieder,et al.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations , 2011, Nature Genetics.

[11]  R. Tenconi,et al.  Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C , 2011, American journal of medical genetics. Part A.

[12]  A. Barrett,et al.  New aids for the non‐invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell‐free fetal DNA in maternal plasma , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[13]  B. Neel,et al.  MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation. , 2011, The Journal of clinical investigation.

[14]  G. Cote,et al.  Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. , 2011, Thyroid : official journal of the American Thyroid Association.

[15]  Stephen R Quake,et al.  Whole-genome molecular haplotyping of single cells , 2011, Nature Biotechnology.

[16]  A. Buja,et al.  RareDeNovoandTransmittedCopy-NumberVariation in Autistic Spectrum Disorders , 2011 .

[17]  L. Petersen,et al.  Paternal age at birth of first child and risk of schizophrenia. , 2011, The American journal of psychiatry.

[18]  S. Y. Park,et al.  Non-invasive prenatal detection of achondroplasia using circulating fetal DNA in maternal plasma , 2011, Journal of Assisted Reproduction and Genetics.

[19]  J. Seidman,et al.  Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutation. , 2010, The Journal of clinical investigation.

[20]  Christian Gilissen,et al.  A de novo paradigm for mental retardation , 2010, Nature Genetics.

[21]  Deborah A Nickerson,et al.  De novo rates and selection of large copy number variation. , 2010, Genome research.

[22]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[23]  Alexander R. Griffing,et al.  Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. , 2010, American journal of human genetics.

[24]  Allon M. Klein,et al.  Mouse germ line stem cells undergo rapid and stochastic turnover. , 2010, Cell stem cell.

[25]  A. Kozubík,et al.  FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence , 2010 .

[26]  A. Wilkie,et al.  Missing heritability: paternal age effect mutations and selfish spermatogonia , 2010, Nature Reviews Genetics.

[27]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[28]  H. Firth,et al.  Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in “paternal age-effect” syndromes , 2010, American journal of medical genetics. Part A.

[29]  Alan Hodgkinson,et al.  The Genomic Distribution and Local Context of Coincident SNPs in Human and Chimpanzee , 2010, Genome biology and evolution.

[30]  A. Kozubík,et al.  FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence. , 2010, Bone.

[31]  Zhixian Yang,et al.  Analysis of SCN1A mutation and parental origin in patients with Dravet syndrome , 2010, Journal of Human Genetics.

[32]  J. Lupski,et al.  Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability. , 2010, American journal of human genetics.

[33]  Paolo Vineis,et al.  A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer , 2010, Nature Genetics.

[34]  Wolfgang Schulze,et al.  Screening for biomarkers of spermatogonia within the human testis: a whole genome approach. , 2010, Human reproduction.

[35]  P. Shannon,et al.  Analysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing , 2010, Science.

[36]  Fyodor A Kondrashov,et al.  Measurements of spontaneous rates of mutations in the recent past and the near future , 2010, Philosophical Transactions of the Royal Society B: Biological Sciences.

[37]  D. Cyr,et al.  Surfing the wave, cycle, life history, and genes/proteins expressed by testicular germ cells. Part 1: Background to spermatogenesis, spermatogonia, and spermatocytes , 2010, Microscopy research and technique.

[38]  J. Kere,et al.  Genomic landscape of positive natural selection in Northern European populations , 2010, European Journal of Human Genetics.

[39]  X. Bao,et al.  Analysis of the Parental Origin of De Novo MECP2 Mutations and X Chromosome Inactivation in 24 Sporadic Patients With Rett Syndrome in China , 2010, Journal of child neurology.

[40]  A. Olshan,et al.  Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004. , 2010, Annals of epidemiology.

[41]  Deborah L. Levy,et al.  A recurrent 16p12.1 microdeletion suggests a two-hit model for severe developmental delay , 2010, Nature Genetics.

[42]  F. Raue,et al.  Update multiple endocrine neoplasia type 2 , 2010, Familial Cancer.

[43]  B. Gelb,et al.  Noonan Syndrome: Clinical Aspects and Molecular Pathogenesis , 2010, Molecular Syndromology.

[44]  M. Lynch.  Rate, molecular spectrum, and consequences of human mutation , 2010, Proceedings of the National Academy of Sciences.

[45]  S. Turner,et al.  Real-time DNA sequencing from single polymerase molecules. , 2010, Methods in enzymology.

[46]  S. Kéri,et al.  Neuregulin 1-stimulated phosphorylation of AKT in psychotic disorders and its relationship with neurocognitive functions , 2009, Neurochemistry International.

[47]  P. Hunt,et al.  Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew , 2009, Current opinion in pediatrics.

[48]  L. Croen,et al.  Risk of autism and increasing maternal and paternal age in a large north American population. , 2009, American journal of epidemiology.

[49]  G. McVean,et al.  Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors , 2009, Nature Genetics.

[50]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[51]  S. Sommer,et al.  Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer , 2009, PloS one.

[52]  Xin Duan,et al.  DISC1 Regulates New Neuron Development in the Adult Brain via Modulation of AKT-mTOR Signaling through KIAA1212 , 2009, Neuron.

[53]  M. Hurles,et al.  Copy number variation in human health, disease, and evolution. , 2009, Annual review of genomics and human genetics.

[54]  J. Lupski,et al.  Mechanisms of change in gene copy number , 2009, Nature Reviews Genetics.

[55]  B. Ng,et al.  De novo apparently balanced translocations in man are predominantly paternal in origin and associated with a significant increase in paternal age , 2009, Journal of Medical Genetics.

[56]  I. Scheffer,et al.  De novo SCN1A mutations in Dravet syndrome and related epileptic encephalopathies are largely of paternal origin , 2009, Journal of Medical Genetics.

[57]  M. Oshimura,et al.  Genetic reconstruction of mouse spermatogonial stem cell self-renewal in vitro by Ras-cyclin D2 activation. , 2009, Cell stem cell.

[58]  Rivka L. Glaser,et al.  The Ups and Downs of Mutation Frequencies during Aging Can Account for the Apert Syndrome Paternal Age Effect , 2009, PLoS genetics.

[59]  A. Munnich,et al.  Thanatophoric dysplasia caused by double missense FGFR3 mutations , 2009, American journal of medical genetics. Part A.

[60]  Xin Zhou,et al.  Multiplex fluorescent PCR for noninvasive prenatal detection of fetal-derived paternally inherited diseases using circulatory fetal DNA in maternal plasma. , 2009, European journal of obstetrics, gynecology, and reproductive biology.

[61]  M. Tartaglia,et al.  Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations , 2009, American journal of medical genetics. Part A.

[62]  P. Hurlin,et al.  The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects , 2009, Human molecular genetics.

[63]  S. Warren,et al.  Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants. , 2009, American journal of human genetics.

[64]  G. Rosenberger,et al.  Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome , 2009, Human mutation.

[65]  A. Barnett,et al.  Advanced Paternal Age Is Associated with Impaired Neurocognitive Outcomes during Infancy and Childhood , 2009, PLoS medicine.

[66]  S. Saitta,et al.  MAP'ing CNS Development and Cognition: An ERKsome Process , 2009, Neuron.

[67]  M C O'Donovan,et al.  Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2 , 2009, Molecular Psychiatry.

[68]  S. Turner,et al.  Real-Time DNA Sequencing from Single Polymerase Molecules , 2009, Science.

[69]  Russell S. Kirby,et al.  Advanced Parental Age and the Risk of Autism Spectrum Disorder , 2008, American journal of epidemiology.

[70]  Y. Elgersma,et al.  Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases. , 2008, Trends in genetics : TIG.

[71]  H. Matsuzaki,et al.  Paternal age at birth and high-functioning autistic-spectrum disorder in offspring , 2008, British Journal of Psychiatry.

[72]  G. Shaw,et al.  The population‐based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US , 2008, American journal of medical genetics. Part A.

[73]  Kun Chen,et al.  Association between H-RAS T81C genetic polymorphism and gastrointestinal cancer risk: A population based case-control study in China , 2008, BMC Cancer.

[74]  C. Hultman,et al.  Advancing paternal age and bipolar disorder. , 2008, Archives of general psychiatry.

[75]  Y. Matsubara,et al.  The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders , 2008, Human mutation.

[76]  Christopher Y. Park,et al.  Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects , 2008, Nature Genetics.

[77]  N. Arnheim,et al.  A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations , 2008, Proceedings of the National Academy of Sciences.

[78]  C. Amos,et al.  Relative effects of mutability and selection on single nucleotide polymorphisms in transcribed regions of the human genome , 2008, BMC Genomics.

[79]  Y. Giudicelli,et al.  Increased achondroplasia mutation frequency with advanced age and evidence for G1138A mosaicism in human testis biopsies. , 2008, Fertility and sterility.

[80]  D. Krewski,et al.  Paternal age and adverse birth outcomes: teenager or 40+, who is at risk? , 2008, Human reproduction.

[81]  H. Toriello,et al.  Statement on guidance for genetic counseling in advanced paternal age , 2008, Genetics in Medicine.

[82]  Joseph A. Gogos,et al.  Strong association of de novo copy number mutations with sporadic schizophrenia , 2008, Nature Genetics.

[83]  S. Krajewski,et al.  Development of diabesity in mice with neuronal deletion of Shp2 tyrosine phosphatase. , 2008, The American journal of pathology.

[84]  Julian Parkhill,et al.  Single-cell genomics , 2008, Nature Reviews Microbiology.

[85]  E. Moreno.  Is cell competition relevant to cancer? , 2008, Nature Reviews Cancer.

[86]  D. Horn,et al.  Mutation and phenotypic spectrum in patients with cardio‐facio‐cutaneous and Costello syndrome , 2007, Clinical genetics.

[87]  N. Carter,et al.  Germline rates of de novo meiotic deletions and duplications causing several genomic disorders , 2008, Nature Genetics.

[88]  J. Lupski,et al.  A DNA Replication Mechanism for Generating Nonrecurrent Rearrangements Associated with Genomic Disorders , 2007, Cell.

[89]  G. De Backer,et al.  Paternal age at birth is an important determinant of offspring telomere length. , 2007, Human molecular genetics.

[90]  Kyle Summers,et al.  Adaptive evolution of genes underlying schizophrenia , 2007, Proceedings of the Royal Society B: Biological Sciences.

[91]  E. Spector,et al.  Familial acanthosis nigricans due to K650T FGFR3 mutation. , 2007, Archives of dermatology.

[92]  R. Brinster,et al.  Glial Cell Line-derived Neurotrophic Factor Regulation of Genes Essential for Self-renewal of Mouse Spermatogonial Stem Cells Is Dependent on Src Family Kinase Signaling* , 2007, Journal of Biological Chemistry.

[93]  N. Arnheim,et al.  The Molecular Anatomy of Spontaneous Germline Mutations in Human Testes , 2007, PLoS biology.

[94]  X. Coumoul,et al.  RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis , 2007, Nature Genetics.

[95]  F. Real,et al.  Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. , 2007, The Journal of investigative dermatology.

[96]  N. Skakkebaek,et al.  Preserved fertility in a non-mosaic Klinefelter patient with a mutation in the fibroblast growth factor receptor 3 gene: case report. , 2007, Human reproduction.

[97]  A. Molven,et al.  De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features , 2007, Journal of Medical Genetics.

[98]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[99]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[100]  S. Toyokuni,et al.  Akt mediates self-renewal division of mouse spermatogonial stem cells , 2007, Development.

[101]  M. Ahmadian,et al.  Myopathy caused by HRAS germline mutations: implications for disturbed myogenic differentiation in the presence of constitutive HRas activation , 2007, Journal of Medical Genetics.

[102]  Claudio Carta,et al.  Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome , 2007, Human mutation.

[103]  A. Wilkie,et al.  Clinical hypochondroplasia in a family caused by a heterozygous double mutation in FGFR3 encoding GLY380LYS , 2007, American journal of medical genetics. Part A.

[104]  Y. Nabeshima,et al.  Functional identification of the actual and potential stem cell compartments in mouse spermatogenesis. , 2007, Developmental cell.

[105]  E. Rajpert-De Meyts.  Recent advances and future directions in research on testicular germ cell cancer. , 2007, International journal of andrology.

[106]  K. Czene,et al.  Parental age and risk of childhood cancers: a population-based cohort study from Sweden. , 2006, International journal of epidemiology.

[107]  J. Hoffman,et al.  Somatic mosaicism for an HRAS mutation causes Costello syndrome , 2006, American journal of medical genetics. Part A.

[108]  G. Davey Smith,et al.  Advanced paternal age: How old is too old? , 2006, Journal of Epidemiology and Community Health.

[109]  J. Böhm,et al.  SALL1 mutations in sporadic Townes–Brocks syndrome are of predominantly paternal origin without obvious paternal age effect , 2006, American journal of medical genetics. Part A.

[110]  Michael Lachmann,et al.  Evolution of primate gene expression , 2006, Nature Reviews Genetics.

[111]  K. Gripp,et al.  Paternal bias in parental origin of HRAS mutations in Costello syndrome , 2006, Human mutation.

[112]  A. Balmain,et al.  A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice , 2006, Nature Genetics.

[113]  T. Abraham,et al.  Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. , 2006, Oral oncology.

[114]  H. Brunner,et al.  The origin of EFNB1 mutations in craniofrontonasal syndrome: frequent somatic mosaicism and explanation of the paucity of carrier males. , 2006, American journal of human genetics.

[115]  R. Hard,et al.  Fibroblast growth factor receptor signaling affects development and function of dopamine neurons – inhibition results in a schizophrenia‐like syndrome in transgenic mice , 2006, Journal of neurochemistry.

[116]  Vip Viprakasit,et al.  A Regulatory SNP Causes a Human Genetic Disease by Creating a New Transcriptional Promoter , 2006, Science.

[117]  Hans O Kalkman,et al.  The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. , 2006, Pharmacology & therapeutics.

[118]  Francesca Chiaromonte,et al.  Strong and weak male mutation bias at different sites in the primate genomes: insights from the human-chimpanzee comparison. , 2006, Molecular biology and evolution.

[119]  P. Rump,et al.  Severe complications in a child with achondroplasia and two FGFR3 mutations on the same allele , 2006, American journal of medical genetics. Part A.

[120]  W. Reardon,et al.  Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases , 2005, Journal of Medical Genetics.

[121]  J. Crow.  Age and sex effects on human mutation rates: an old problem with new complexities. , 2006, Journal of radiation research.

[122]  M. Knaap,et al.  Propensity for paternal inheritance of de novo mutations in Alexander disease , 2006, Human Genetics.

[123]  Pawel Stankiewicz,et al.  Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes , 2005, PLoS genetics.

[124]  D. Noh,et al.  Association of paternal age at birth and the risk of breast cancer in offspring: a case control study , 2005, BMC Cancer.

[125]  K. Yutzey,et al.  Noonan Syndrome Mutation Q79R in Shp2 Increases Proliferation of Valve Primordia Mesenchymal Cells via Extracellular Signal–Regulated Kinase 1/2 Signaling , 2005, Circulation research.

[126]  Yukichi Tanaka,et al.  Germline mutations in HRAS proto-oncogene cause Costello syndrome , 2005, Nature Genetics.

[127]  A. Wilkie,et al.  Fibroblast growth factor receptor 2, gain‐of‐function mutations, and tumourigenesis: investigating a potential link , 2005, The Journal of pathology.

[128]  Timothy B Sackton,et al.  A Scan for Positively Selected Genes in the Genomes of Humans and Chimpanzees , 2005, PLoS biology.

[129]  G. McVean,et al.  Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[130]  E. Grice,et al.  A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk , 2005, Nature.

[131]  A. Wilkie.  Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. , 2005, Cytokine & growth factor reviews.

[132]  Robert J. Linhardt,et al.  Analysis of Mutations in Fibroblast Growth Factor (FGF) and a Pathogenic Mutation in FGF Receptor (FGFR) Provides Direct Evidence for the Symmetric Two-End Model for FGFR Dimerization , 2005, Molecular and Cellular Biology.

[133]  Christine M. Malcom,et al.  Accelerated Evolution of Nervous System Genes in the Origin of Homo sapiens , 2004, Cell.

[134]  R. Brinster,et al.  Growth factors essential for self-renewal and expansion of mouse spermatogonial stem cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[135]  Nobuyuki Itoh,et al.  Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. , 2004, Human molecular genetics.

[136]  M. Patton,et al.  Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome. , 2004, American journal of human genetics.

[137]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[138]  A. V. D. van den Ouweland,et al.  Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis , 2004, Human Genetics.

[139]  Konrad Basler,et al.  dMyc Transforms Cells into Super-Competitors , 2004, Cell.

[140]  Rivka L. Glaser,et al.  The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm. , 2003, American journal of human genetics.

[141]  E. Jabs,et al.  Parental origin of mutations in sporadic cases of Treacher Collins syndrome , 2003, European Journal of Human Genetics.

[142]  G. McVean,et al.  Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ Line , 2003, Science.

[143]  H. Ewald,et al.  Parental age and risk of schizophrenia: a case-control study. , 2003, Archives of general psychiatry.

[144]  Alexey S Kondrashov,et al.  Direct estimates of human per nucleotide mutation rates at 20 loci causing mendelian diseases , 2003, Human mutation.

[145]  J. Brockmöller,et al.  A single nucleotide polymorphism in the human H-ras proto-oncogene determines the risk of urinary bladder cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[146]  N. Arnheim,et al.  The observed human sperm mutation frequency cannot explain the achondroplasia paternal age effect , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[147]  A. V. D. van den Ouweland,et al.  FGFs, their receptors, and human limb malformations: clinical and molecular correlations. , 2002, American journal of medical genetics.

[148]  P. Nowell.  Tumor progression: a brief historical perspective. , 2002, Seminars in cancer biology.

[149]  Kateryna D. Makova,et al.  Strong male-driven evolution of DNA sequences in humans and apes , 2002, Nature.

[150]  C. Fahim,et al.  Paternal age and sporadic schizophrenia: evidence for de novo mutations. , 2002, American journal of medical genetics.

[151]  E. Zackai,et al.  Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. , 2002, American journal of human genetics.

[152]  A. Gavin,et al.  Association of early life factors and acute lymphoblastic leukaemia in childhood: historical cohort study , 2002, British Journal of Cancer.

[153]  P. V. van Diest,et al.  Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918. , 2002, The Journal of clinical endocrinology and metabolism.

[154]  W. Foulkes,et al.  Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET , 2001, Journal of medical genetics.

[155]  P. Huppke,et al.  MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. , 2001, American journal of human genetics.

[156]  M. Saarma,et al.  Promotion of seminomatous tumors by targeted overexpression of glial cell line-derived neurotrophic factor in mouse testis. , 2001, Cancer research.

[157]  J. Chelly,et al.  Parental origin of de novo MECP2 mutations in Rett syndrome , 2001, European Journal of Human Genetics.

[158]  L D Edmonds,et al.  The National Birth Defects Prevention Study , 2001, Public health reports.

[159]  D. Malaspina,et al.  Paternal factors and schizophrenia risk: de novo mutations and imprinting. , 2001, Schizophrenia bulletin.

[160]  S. Rosengren,et al.  Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. , 2000, American journal of human genetics.

[161]  J. Crow.  The origins, patterns and implications of human spontaneous mutation , 2000, Nature Reviews Genetics.

[162]  M. Nachman,et al.  Estimate of the mutation rate per nucleotide in humans. , 2000, Genetics.

[163]  Rivka L. Glaser,et al.  Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. , 2000, American journal of human genetics.

[164]  M. Saarma,et al.  Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. , 2000, Science.

[165]  M. Ichihara,et al.  A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations. , 2000, Biochemical and biophysical research communications.

[166]  Z. Vajo,et al.  The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. , 2000, Endocrine reviews.

[167]  G. Risbridger,et al.  Discrete cell- and stage-specific localisation of fibroblast growth factors and receptor expression during testis development. , 2000, The Journal of endocrinology.

[168]  M. Rothmund,et al.  A RET double mutation in the germline of a kindred with FMTC. , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[169]  M. Muenke,et al.  Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome , 1999, Human Genetics.

[170]  A. Miyauchi,et al.  Two Germline Missense Mutations at Codons 804 and 806 of the RET Proto‐oncogene in the Same Allele in a Patient with Multiple Endocrine Neoplasia Type 2B without Codon 918 Mutation , 1999, Japanese journal of cancer research : Gann.

[171]  M. Gonzalès,et al.  Clinical variability in patients with Apert's syndrome. , 1999, Journal of neurosurgery.

[172]  A. Munnich,et al.  Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. , 1998, American journal of human genetics.

[173]  J. A. Harris,et al.  Birth prevalence, mutation rate, sex ratio, parents' age, and ethnicity in Apert syndrome. , 1997, American journal of medical genetics.

[174]  L. Mulligan,et al.  Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. , 1997, The Journal of clinical endocrinology and metabolism.

[175]  B. Ponder,et al.  Germline mutation of RET codon 883 in two cases of de novo MEN 2B , 1997, Oncogene.

[176]  C. Eng,et al.  Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma [4] , 1997 .

[177]  G M Lenoir,et al.  Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine. , 1997, American journal of human genetics.

[178]  E. Zackai,et al.  Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2. , 1997, Human molecular genetics.

[179]  C. Richards,et al.  Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. , 1996, The Journal of clinical endocrinology and metabolism.

[180]  Steven A. Wall,et al.  Exclusive paternal origin of new mutations in Apert syndrome , 1996, Nature Genetics.

[181]  G. Scarano,et al.  Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfecta. , 1995, American journal of medical genetics.

[182]  P. Goodfellow,et al.  Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B. , 1995, Human Molecular Genetics.

[183]  D. Rimoin,et al.  Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3 , 1995, Nature Genetics.

[184]  I. Kaitila,et al.  Achondroplasia is defined by recurrent G380R mutations of FGFR3. , 1995, American journal of human genetics.

[185]  W. Reardon,et al.  Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome , 1995, Nature Genetics.

[186]  P. Goodfellow,et al.  Parent-of-origin effects in multiple endocrine neoplasia type 2B. , 1994, American journal of human genetics.

[187]  R. Brinster,et al.  Spermatogenesis following male germ-cell transplantation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[188]  T. van Vroonhoven,et al.  Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. , 1994, The New England journal of medicine.

[189]  Arnold Munnich,et al.  Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia , 1994, Nature.

[190]  D. Clayton,et al.  Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC , 1994, Nature Genetics.

[191]  B. Ponder,et al.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.

[192]  S. Kreiborg,et al.  Birth prevalence study of the Apert syndrome. , 1992, American journal of medical genetics.

[193]  M. Burch,et al.  A clinical study of Noonan syndrome. , 1992, Archives of disease in childhood.

[194]  C. Stoll,et al.  Birth prevalence rates of skeletal dysplasias , 1989, Clinical genetics.

[195]  N. Risch,et al.  Spontaneous mutation and parental age in humans. , 1987, American journal of human genetics.

[196]  M. Wigler,et al.  Analysis of the transforming potential of the human H-ras gene by random mutagenesis. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[197]  R. Dymock,et al.  SPERMATOCYTIC SEMINOMA , 1976, The Medical journal of Australia.

[198]  F Vogel,et al.  Spontaneous mutation in man. , 1975, Advances in human genetics.

[199]  L. Penrose.  Parental age and mutation. , 1955, Lancet.